Cancer Colorectal Cancer or Colon Cancer

Table of Contents

RECENT HIGHLIGHTS AND CHANGES
--Recent Highlights and Changes
UPCOMING PATENT EXPIRES BY THERAPY AREA
Colorectal Cancer or Colon Cancer Pipeline Overview
--% of Projects (By Phase of Development)
--No. of Projects by Phase of Development
--Marketed Products Vs. Pipeline Products
Company Overview - Pipeline Projects
--Company Overview - Pipeline Projects

--Top Companies in late stage Colorectal Cancer or Colon Cancer Projects
--Alchemia Ltd
--Abbott Laboratories
--Antigenics Inc
--Amgen Inc
--Bayer Ag
--AstraZeneca Plc
--Eli Lilly & Co
--Bristol-Myers Squibb Company
--Imclone Systems Inc
--Genentech Inc
--Merck KGaA
--INTRACEL Corp
--Oxford BioMedica plc
--Onyx Pharmaceuticals Inc
--Pro-Pharmaceuticals Inc
--Pfizer Inc
--Sanofi-Aventis
--Roche Holdings Ltd
--Wyeth
--Vaccinogen, Inc.

--Top Companies in early stage Colorectal Cancer or Colon Cancer Projects
--Anavex Life Sciences Corp.
--Amgen Inc
--Aphios Corporation
--Antisense Pharma GmbH
--Biocompatibles International plc
--Arana Therapeutics Limited
--BioVex Inc
--Bionovo Inc
--D-Pharm Ltd
--Bristol-Myers Squibb Company
--NicOx S.A.
--NatImmune A/S
--Plexxikon Inc
--Pharmexa A/S
--Protiva Biotherapeutics Inc
--Prolexys Pharmaceuticals, Inc
--Roche Holdings Ltd
--Raven biotechnologies, inc.
--Topotarget A/S
--Takeda Pharmaceutical Company Limited

Pipeline Revenue
--Pipeline Revenue
Full Pipeline View
--Pre Clinical Pipeline View
--Phase I Pipeline View
--Phase II Pipeline View
--Phase III Pipeline View
--Pending Approval Pipeline View
--Approved Pipeline View
--Post Marketing Pipeline View
--On the Market Pipeline View
--Discovery/Development Pipeline View